UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 80

Sortiert nach

vsgoftest : An R Package for Goodness-of-Fit Testing Based on Kullback-Leibler Divergence

Journal of statistical software, 2020-12, Vol.96 (Code Snippet 1)

2020

Volltextzugriff (PDF)

Circulating PIK3CA mutation detection at diagnosis in non-metastatic inflammatory breast cancer patients

Scientific reports, 2021-12, Vol.11 (1), p.24041-24041, Article 24041

2021

Volltextzugriff (PDF)

Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol

BMC cancer, 2019-03, Vol.19 (1), p.198-11, Article 198

2019

Volltextzugriff (PDF)

Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective study

Haematologica (Roma), 2021-01, Vol.106 (1), p.154

2021

Volltextzugriff (PDF)

Inflammation at diagnosis and cognitive impairment two years later in breast cancer patients from the Canto-Cog study

Breast cancer research : BCR, 2024-06, Vol.26 (1), p.1-10, Article 93

2024

Volltextzugriff (PDF)

A goodness-of-fit test of student distributions based on Rényi entropy

AIP Conference Proceedings, 2015, Vol.1641 (1), p.494

Lequesne Justine

2015

Volltextzugriff (PDF)

TALASUR trial: a single arm phase II trial assessing efficacy and safety of TALazoparib and Avelumab as maintenance therapy in platinum-Sensitive metastatic or locally advanced URothelial carcinoma

BMC cancer, 2022-11, Vol.22 (1), p.1213-11, Article 1213

2022

Volltextzugriff (PDF)

Cognitive assessment in patients treated by immunotherapy: the prospective Cog-Immuno trial

BMC cancer, 2022-12, Vol.22 (1), p.1308-1308, Article 1308

2022

Volltextzugriff (PDF)

Risk of early progression according to circulating ESR1 mutation, CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancer

Breast cancer research : BCR, 2020-05, Vol.22 (1), p.56-56, Article 56

2020

Volltextzugriff (PDF)

Impact of Taxanes, Endocrine Therapy, and Deleterious Germline BRCA Mutations on Anti-müllerian Hormone Levels in Early Breast Cancer Patients Treated With Anthracycline- and Cyclophosphamide-Based Chemotherapy

Frontiers in oncology, 2019-07, Vol.9, p.575-575

2019

Volltextzugriff (PDF)

Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a phase II study (GASPAR)

BMC cancer, 2022-05, Vol.22 (1), p.537-537, Article 537

2022

Volltextzugriff (PDF)

HELENA: HER2-Low as a prEdictive factor of response to Neoadjuvant chemotherapy in eArly breast cancer

BMC cancer, 2022-10, Vol.22 (1), p.1-1081, Article 1081

2022

Volltextzugriff (PDF)

Diagnostic and prognostic value of a 7-panel mutation testing in thyroid nodules with indeterminate cytology: the SWEETMAC study

Endocrine, 2021-02, Vol.71 (2), p.407-417

2021

Volltextzugriff (PDF)

Effects of sleep disturbances and circadian rhythms modifications on cognition in breast cancer women before and after adjuvant chemotherapy: the ICANSLEEP-1 protocol

BMC cancer, 2023-12, Vol.23 (1), p.1178-1178, Article 1178

2023

Volltextzugriff (PDF)

Impact of the Bayesian penalized likelihood algorithm (Q.Clear®) in comparison with the OSEM reconstruction on low contrast PET hypoxic images

EJNMMI physics, 2020-05, Vol.7 (1), p.28-28, Article 28

2020

Volltextzugriff (PDF)

Simultaneous integrated boost on pathologic lymph nodes safely improves clinical outcomes compared to sequential boost in locally advanced cervical cancer: a multicenter retrospective study

Frontiers in oncology, 2024-06, Vol.14, p.1353813

2024

Volltextzugriff (PDF)

Stereotactic ablative radiotherapy and systemic treatments for extracerebral oligometastases, oligorecurrence, oligopersistence and oligoprogression from lung cancer

BMC cancer, 2019-12, Vol.19 (1), p.1237-1237, Article 1237

2019

Volltextzugriff (PDF)

CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure

BMC cancer, 2021-09, Vol.21 (1), p.1054-12, Article 1054

2021

Volltextzugriff (PDF)

Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer)

Radiation oncology (London, England), 2018-07, Vol.13 (1), p.138-138, Article 138

2018

Volltextzugriff (PDF)

Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer

Radiation oncology (London, England), 2020-05, Vol.15 (1), p.116-9, Article 116

2020

Volltextzugriff (PDF)

Pretreatment neutrophil to lymphocyte ratio as prognostic factor in metastatic breast cancer treated with cyclin dependent kinase 4/6 inhibitors

Frontiers in oncology, 2023-01, Vol.12, p.1105587-1105587

2023

Volltextzugriff (PDF)

Post-traumatic stress disorder symptoms and associated factors in breast cancer patients during the first COVID-19 lockdown in France

Frontiers in psychology, 2022-09, Vol.13, p.768043-768043

2022

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(71)

Publikationsform

Artikel
(79)
Tagungsberichte
(1)

Sprache

Englisch
(80)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

vsgoftest : An R Package for Goodness-of-Fit Testing Based on Kullback-Leibler Divergence

Circulating PIK3CA mutation detection at diagnosis in non-metastatic inflammatory breast cancer patients

Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol

Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective study

Inflammation at diagnosis and cognitive impairment two years later in breast cancer patients from the Canto-Cog study

A goodness-of-fit test of student distributions based on Rényi entropy

TALASUR trial: a single arm phase II trial assessing efficacy and safety of TALazoparib and Avelumab as maintenance therapy in platinum-Sensitive metastatic or locally advanced URothelial carcinoma

Cognitive assessment in patients treated by immunotherapy: the prospective Cog-Immuno trial

Risk of early progression according to circulating ESR1 mutation, CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancer

Impact of Taxanes, Endocrine Therapy, and Deleterious Germline BRCA Mutations on Anti-müllerian Hormone Levels in Early Breast Cancer Patients Treated With Anthracycline- and Cyclophosphamide-Based Chemotherapy

Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a phase II study (GASPAR)

The TRIPLEX study: use of patient-derived tumor organoids as an innovative tool for precision medicine in triple-negative breast cancer

HELENA: HER2-Low as a prEdictive factor of response to Neoadjuvant chemotherapy in eArly breast cancer

Diagnostic and prognostic value of a 7-panel mutation testing in thyroid nodules with indeterminate cytology: the SWEETMAC study

Effects of sleep disturbances and circadian rhythms modifications on cognition in breast cancer women before and after adjuvant chemotherapy: the ICANSLEEP-1 protocol

Impact of the Bayesian penalized likelihood algorithm (Q.Clear®) in comparison with the OSEM reconstruction on low contrast PET hypoxic images

ORGAVADS: establishment of tumor organoids from head and neck squamous cell carcinoma to assess their response to innovative therapies

Simultaneous integrated boost on pathologic lymph nodes safely improves clinical outcomes compared to sequential boost in locally advanced cervical cancer: a multicenter retrospective study

Stereotactic ablative radiotherapy and systemic treatments for extracerebral oligometastases, oligorecurrence, oligopersistence and oligoprogression from lung cancer

CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure

The OVAREX study: Establishment of ex vivo ovarian cancer models to validate innovative therapies and to identify predictive biomarkers

Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer)

Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer

Pretreatment neutrophil to lymphocyte ratio as prognostic factor in metastatic breast cancer treated with cyclin dependent kinase 4/6 inhibitors

Post-traumatic stress disorder symptoms and associated factors in breast cancer patients during the first COVID-19 lockdown in France

Suchergebnisse filtern